Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept Randomized, Double-blind, Parallel Group, Controlled Dose-finding and Safety Study of STR-324 in Post-operative Pain

NCT04582786 is registered in ClinicalTrials.gov with Alaxia SAS as lead sponsor.

NCT NCT04582786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04582786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept Randomized, Double-blind, Parallel Group, Controlled Dose-finding and Safety Study of STR-324 in Post-operative Pain
Lead sponsor
Alaxia SAS
Phase
Phase 2
Overall status
Unknown status
Start date
December 1, 2020
Completion date
January 31, 2022
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, acute